Goniowash: a new surgical approach combined with cataract surgery to lower intraocular pressure in pseudoexfoliation syndrome.
Cataract
Glaucoma
Goniowash
Irrigation cannula
Pseudoexfoliation
Journal
International ophthalmology
ISSN: 1573-2630
Titre abrégé: Int Ophthalmol
Pays: Netherlands
ID NLM: 7904294
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
16
03
2020
accepted:
29
05
2020
pubmed:
28
6
2020
medline:
22
6
2021
entrez:
28
6
2020
Statut:
ppublish
Résumé
Pseudoexfoliation syndrome is common in elderly patients and is associated with intraocular pressure elevation. Goniowash is a novel surgical technique to remove pseudoexfoliation material from the irido-corneal angle to decrease intraocular pressure. We assessed the long-term efficacy of Goniowash on relevant parameters in patients with pseudoexfoliation syndrome, after cataract surgery. The study enrolled 122 patients with pseudoexfoliation syndrome, who underwent routine cataract surgery combined with Goniowash. Best-corrected visual acuity, intraocular pressure and medication status were recorded in study participants during 5 years of follow-up. Data from 190 eyes (122 patients of average age 73.8 ± 7.7 years) were assessed. Mean best-corrected visual acuity increased from 0.60 to 1.0 (p < 0.001) one year after surgery and remained stable throughout the follow-up. Average intraocular pressure decreased from 26.4 ± 7.3 mmHg pre-operatively to 15.9 ± 3.0 mmHg post operatively at one year (p < 0.001), 16.1 ± 3.3 mmHg (p < 0.001) at 3 years and 16.8 ± 2.9 (p < 0.001) at 5 years. Mean number of ocular hypotensive medications decreased from 1.5 ± 0.8 pre-operatively to 0.4 ± 0.7 post-operatively (75% reduction) (p < 0.001). No unexpected and severe adverse events related to the surgical procedure were reported. Goniowash combined with cataract surgery provides stable and long-lasting reduction of intraocular pressure and hypotensive medications. It is a safe procedure and may be an alternative for patients with pseudoexfoliation syndrome and elevated intraocular pressure.
Identifiants
pubmed: 32592126
doi: 10.1007/s10792-020-01459-5
pii: 10.1007/s10792-020-01459-5
pmc: PMC8087560
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1563-1571Références
J Curr Ophthalmol. 2015 Nov 25;27(1-2):12-5
pubmed: 27239568
Clin Exp Ophthalmol. 2004 Apr;32(2):199-210
pubmed: 15068440
Invest Ophthalmol Vis Sci. 1995 Aug;36(9):1750-64
pubmed: 7635652
Clin Ophthalmol. 2015 May 22;9:907-19
pubmed: 26045655
Acta Ophthalmol Scand. 2007 Aug;85(5):495-9
pubmed: 17590201
Ophthalmology. 2015 Jul;122(7):1283-93
pubmed: 25972254
Br J Ophthalmol. 2006 Aug;90(8):1014-8
pubmed: 16672324
J Cataract Refract Surg. 2001 Apr;27(4):528-32
pubmed: 11311618
Ophthalmology. 1998 May;105(5):886-94
pubmed: 9593393
J Cataract Refract Surg. 2008 Nov;34(11):1834-41
pubmed: 19006727
Curr Opin Ophthalmol. 1997 Apr;8(2):73-9
pubmed: 10168362
Ophthalmology. 2000 Mar;107(3):417-21
pubmed: 10711875
Surv Ophthalmol. 2001 Jan-Feb;45(4):265-315
pubmed: 11166342
J Cataract Refract Surg. 2007 Jul;33(7):1209-16
pubmed: 17586377
J Cataract Refract Surg. 2003 Jun;29(6):1080-6
pubmed: 12842671
Arch Ophthalmol. 1992 Dec;110(12):1752-6
pubmed: 1463418
Int Ophthalmol. 2015 Apr;35(2):209-14
pubmed: 24706084
Arch Ophthalmol. 1992 Dec;110(12):1757-62
pubmed: 1463419
Graefes Arch Clin Exp Ophthalmol. 1992;230(3):252-7
pubmed: 1597292
J Cataract Refract Surg. 1997 Jan-Feb;23(1):122-5
pubmed: 9100119
Int Ophthalmol. 2009 Oct;29(5):389-92
pubmed: 18651104
Arch Ophthalmol. 2007 Jul;125(7):889-92
pubmed: 17620566
J Ophthalmol. 2015;2015:370371
pubmed: 26605078